Boulding Mark Elliott (CIK 1578852) reported 117 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Buy PTCT (2,813 shares), Sell PTCT (1,844 shares), Sell PTCT (969 shares), Sell PTCT (745 shares), Sell PTCT (313 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,813 | $72,266 |
| 2026-08-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 1,844 | $133,487 |
| 2026-08-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 969 | $70,640 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 745 | $64,353 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 313 | $26,010 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 833 | $70,314 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 519 | $44,551 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 601 | $51,914 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,813 | $130,917 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 387 | $32,160 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 1,036 | $87,449 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 645 | $55,367 |
| 2026-07-08 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,266 | $89,326 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 8,510 | $396,055 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 6,600 | $518,100 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 1,850 | $146,594 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,012 | $93,638 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 1,703 | $133,686 |
| 2026-06-22 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 309 | $24,488 |
| 2026-05-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,812 | $72,240 |
| 2026-05-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 2,356 | $169,820 |
| 2026-05-19 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 456 | $33,138 |
| 2026-05-12 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Buy | 2,740 | $127,520 |
| 2026-05-12 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 840 | $65,713 |
| 2026-05-12 | PTC THERAPEUTICS, INC. (PTCT) | EXEC. VP AND CLO | Sell | 1,900 | $150,689 |
Source: SEC Form 4 filings · as of 2026-08-19